Type I CD20 antibodies take over the B-cell receptor for complement-dependent cytotoxicity (CDC) of malignant B cells

✍ Scribed by Patrick J. Engelberts; Marleen Voorhorst; Janine Schuurman; Tom van Meerten; Joost M. Bakker; Tom Vink; Wendy J.M. Mackus; Jan G.J. van de Winkel; Paul W.H.I. Parren; Frank J. Beurskens

• Book ID: 118459531
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 70 KB
• Volume: 217
• Category: Article
• ISSN: 0171-2985
• DOI: 10.1016/j.imbio.2012.08.254